Dr. Reddy’s Laboratories informs about update

06 Sep 2024 Evaluate

Further to its intimation dated June 7, 2024, on the inspection conducted by the United States Food & Drug Administration (USFDA) at its API manufacturing facility (CTO-6) in Srikakulam, Andhra Pradesh, Dr. Reddy’s Laboratories has informed that the Company has received the Establishment Inspection Report (EIR). The USFDA has classified the inspection as Voluntary Action Indicated (VAI) and concluded that the inspection is ‘closed’ under 21 CFR 20.64(d)(3).

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1326.00 -11.30 (-0.84%)
15-Jan-2025 10:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1765.95
Dr. Reddys Lab 1326.00
Cipla 1451.80
Lupin 2142.95
Zydus Lifesciences 994.50
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.